Company releases May 08, 2023
Maximilian LeRoux appointed as Chief Commercial Officer of Nightingale Health Plc
Nightingale Health Plc
8 May 2023 at 11:45 a.m. EEST
Nightingale Health Plc (”Nightingale Health”) has appointed Maximilian LeRoux as Chief Commercial Officer. LeRoux will join Nightingale Health’s management team as of 1 August 2023 at the latest.
LeRoux has over 20 years’ experience of international business, and he has held a number of commercial leadership positions in sales and marketing, including at Dell Technologies (Texas, US), Savox Communications (Helsinki, Finland and New York, US) and others. LeRoux joins Nightingale Health from Mimi Hearing Technologies, a Berlin based scale-up company and the global leader in sound personalization and hearing wellbeing, where he held a position of Chief Commercial Officer. Before that he was the co-founder and CEO of AINA PTT a company providing critical communications solutions, building the company ground-up to a globally recognized brand within its industry. LeRoux holds a master’s degree in economics from Goethe University in Frankfurt, Germany. At Nightingale Health, LeRoux will have a key role in growing the B2B sales in accordance with the company’s ambitious targets.
Teemu Suna, CEO and co-founder of Nightingale Health:
“We are delighted to announce that Maximilian LeRoux will join Nightingale Health as CCO. LeRoux has experience of working in challenging positions at scale-up companies and larger corporations, as well as building a company from scratch to a successful business, which we highly value. He speaks five languages fluently and has lived and worked in numerous countries, and we believe he has excellent capabilities to grow Nightingale Health’s global business.”
“I am excited to join Nightingale Health as the CCO. I believe that my experience and skills will strengthen Nightingale Health’s leadership team and I look forward to working together to achieve the company’s vision, which can make a huge impact to the accessibility of preventative health. I am impressed by the service and product portfolio Nightingale Health has built, and I think it is the perfect timing to join the team to scale the sales globally.”
For further information, please contact:
Teemu Suna, CEO
Oaklins Merasco Ltd, tel. +358 9 6129 670
About Nightingale Health
Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it’s also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.